Close

Analyst Ratings for Biogen (BIIB)

BIIB Rating Summary

BIIB Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BIIB
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $299.88 (+36.7%) * Over Last 12-Mos
Rating Score: 6.9 / 10   Percentile Rank: 75%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/14/2024 Wells Fargo Mohit Bansal Downgrade Equal Weight
(Overweight)
240.00
(315.00)
226.65
(219.40)
-3.2% Details
1/24/2024 UBS
» Updated 2/16/2024
Colin Bristow Downgrade Neutral
(Buy)
250.00
(276.00)
251.68
(219.40)
-12.83% Details
Like BIIB Ratings? Also take a look at LLY, RETA, IONS, SAGE

BIIB Ratings News